Are biosimilar options available for kadcyla?

Are biosimilars of Kadcyla available yet?

Kadcyla is a complex antibody-drug conjugate that combines trastuzumab with the chemotherapy payload DM1. Antibody-drug conjugates are more difficult to replicate than plain monoclonal antibodies, so biosimilars for Kadcyla have not yet reached the market.